CLINICAL_TRIALS
trial_result
· 2008-07-23
Clinical Trial Update: Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia [Phase 3]
Summary
Phase 3 trial update on intravitreal bevacizumab for idiopathic macular telangiectasia, with the study status shown as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sao Paulo | Conditions: Retina, Telangiectasis | Phase 3 | Status: COMPLETED